From Fermentation To Vaccination

The move toward non-animal-origin excipients is reshaping how high-risk pharmaceutical applications are developed—especially in vaccines. Explore squalene’s critical role in vaccine adjuvants and examine how fermentation-derived, non-animal-origin squalene can match the performance of traditional shark-derived sources while improving supply security and sustainability. The discussion covers sourcing challenges, manufacturing approaches, regulatory considerations, and formulation performance, including stability, purity, and batch-to-batch consistency. Real-world data illustrate how fermentation-based squalene performs in nanoemulsions and supports robust immune responses in vitro.

Watch the full webinar to understand how non-animal-origin squalene supports both vaccine efficacy and responsible innovation.